Ironwood Pharmaceuticals Inc IRWD:NASDAQ

Last Price$13.75NASDAQ Previous Close - Last Trade as of 4:00PM ET 3/25/19

Today's Change+0.13(0.95%)
Bid (Size)$13.74 (5)
Ask (Size)$13.75 (116)
Day Low / High$13.40 - 13.95
Volume1.1 M
  • Latest Stories
  • Commentary and Analysis
Sector Update: Health Care Stocks Paring Mid-Day Slide Near Close
3:55PM ET 3/22/2019 MT Newswires

Top Health Care Stocks JNJ -0.54% PFE -1.00% ABT -2.39% MRK -0.94% AMGN -2.39% Health care stocks retreated Friday afternoon, including a 1.1% decline...

Sector Update: Health Care Stock Grinding Lower This Afternoon
2:13PM ET 3/22/2019 MT Newswires

Top Health Care Stocks JNJ -0.59% PFE -0.62% ABT -2.39% MRK -0.88% AMGN -2.14% Health care stocks were retreating Friday afternoon, including a 1.2%...

Sector Update: Health Care
1:43PM ET 3/22/2019 MT Newswires

Health care stocks were retreating Friday afternoon, including a 1.2% decline for the NYSE Health Care Index in recent trade. Shares of health care...

Analyst Actions: Credit Suisse Lifts Ironwood Pharmaceuticals Price Target to $16 From $15; Maintains at Neutral
10:56AM ET 3/22/2019 MT Newswires

Credit Suisse said Friday it has raised Ironwood Pharmaceuticals (IRWD) price target to $16 from $15, while reiterating its neutral rating. According to...

Insider Selling at Ironwood Pharmaceuticals (IRWD) Continues with Significant Sale
10:17PM ET 3/11/2019 MT Newswires

One Ironwood Pharmaceuticals insider Dr Mark G Currie, Officer, today, sold 275,000 shares having a market value of approximately $3,647,820, as disclosed...

Insider Trends: Insider Sale Reduces 90-Day Buy Trend at Ironwood Pharmaceuticals
5:56PM ET 3/08/2019 MT Newswires

Dr Mark G Currie, Chief Scientific Officer, sold 275,000 shares of Ironwood Pharmaceuticals (IRWD) on Mar 07, 2019, for $3,647,820. Dr Currie, subsequent...

Analyst Actions: HC Wainwright Upgrades Ironwood Pharmaceuticals to Neutral From Sell; Lifts PT to $14 From $11.5
10:19AM ET 2/25/2019 MT Newswires

Ironwood Pharmaceuticals' (IRWD) average rating among analysts is a hold. Price: 14.51, Change: +0.26, Percent Change: +1.82 ...

Insider Trends: 90-Day Insider Buying Trend Slowed with Sale of Ironwood Pharmaceuticals Shares
4:54PM ET 2/22/2019 MT Newswires

On Feb 20, 2019, Chief Legal Officer, Halley E Gilbert, executed a sale of 10,242 shares in Ironwood Pharmaceuticals (IRWD) for $146,564. Gilbert, after...

Ironwood Pharmaceuticals Tops Q4 Street Estimates; to Cut Staff as Part of Separation Plan
9:33AM ET 2/13/2019 MT Newswires

Ironwood Pharmaceuticals (IRWD) on Wednesday reported a Q4 non-GAAP net loss per share of $0.02, compared to a net loss of $0.14 per share in the year-ago...

Analyst Actions: JP Morgan Upgrades Ironwood Pharmaceuticals to Neutral From Underweight; Lifts PT to $13 From $11
10:03AM ET 1/24/2019 MT Newswires

Ironwood Pharmaceuticals' (IRWD) average rating among analysts is a hold, with an average price target of $17. Price: 12.63, Change: +0.21, Percent Change:...